TP53 and acute myeloid leukemia: Although all classes of TP53 variants have been observed in AML, the vast majority of mutations include missense alterations usually arising in the DNA binding domain (encoded by exons 5–8) with a predilection for arginine residues and noted mutational “hot spots” such as R175H, Y220C, R248Q, and R273C (13).